Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
about
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patientsOrthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.Management of recurrent hepatitis C after liver transplantation.Role of living donor liver transplantation in the treatment of hepatitis C virus infectionInterferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
P2860
Q28346817-F7EC83B0-C772-4A2F-8881-16FAA4013054Q33654989-D935DB2D-9D25-4809-B891-3E2FBD1FCF65Q34266517-67C405F0-E39F-4092-AA10-96C47C5782B1Q35540281-BADEA694-5A0E-41B4-87FA-0243CCD1D495Q42990367-CEB6DC3A-ABD3-472F-9606-F2EFB2AD1964Q43859527-A43DFD61-8951-49F6-8471-56DFE7AB3764Q44211421-CD38EF68-AD50-4116-ACA9-148EDA3F5B8D
P2860
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Retransplantation for recurren ...... yclosporine immunosuppression.
@en
Retransplantation for recurren ...... yclosporine immunosuppression.
@nl
type
label
Retransplantation for recurren ...... yclosporine immunosuppression.
@en
Retransplantation for recurren ...... yclosporine immunosuppression.
@nl
prefLabel
Retransplantation for recurren ...... yclosporine immunosuppression.
@en
Retransplantation for recurren ...... yclosporine immunosuppression.
@nl
P2093
P1476
Retransplantation for recurren ...... yclosporine immunosuppression.
@en
P2093
Busuttil RW
Colquhoun S
Ghobrial RM
Goldstein LI
P304
P356
10.1016/S0041-1345(98)00320-0
P407
P577
1998-06-01T00:00:00Z